Richard J. Rodgers - Jun 18, 2025 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
Director
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for Richard J. Rodgers
Stock symbol
ARDX
Transactions as of
Jun 18, 2025
Transactions value $
$0
Form type
4
Date filed
6/23/2025, 08:42 PM
Previous filing
Jun 13, 2025
Next filing
Jun 24, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rodgers Richard J Director C/O ARDELYX, INC., 400 FIFTH AVENUE, SUITE 210, WALTHAM /s/ Elizabeth Grammer, Attorney-in-Fact for Richard J. Rodgers 2025-06-23 0001313397

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Award $0 +21.5K +6.12% $0.00 372K Jun 18, 2025 Direct F1
transaction ARDX Common Stock Award $0 +41.6K +11.17% $0.00 414K Jun 18, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARDX Stock Option (Right to Buy) Award $0 +54.1K $0.00 54.1K Jun 18, 2025 Common Stock 54.1K $3.61 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program.
F2 Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program.
F3 The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program.
F4 The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.